A Pilot Study on the Impact of Two Different Doses of Ciclesonide (160 mcg/Day and 320 mcg/Day) Administered in the Evening on Quality of Life in Patients With Moderate Persistent Asthma
Phase of Trial: Phase III
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 16 Jul 2008 Nycomed reported as trial affliate by ClinicalTrials.gov.
- 01 Feb 2007 Status changed from recruiting.
- 14 Oct 2006 New trial record.